Publications

Main content

e-citations of ETH:

2017

Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability
Katharina F. Hermann, Claudia S. Neuhaus, Virgine Micallef, Björn Wagner, Maja Hatibovic, Hélène E. Aschmann, Franziska Paech, Rubén Alvarez-Sánchez, Stefanie D. Krämer and Sara Belli
European Journal of Pharmaceutical Sciences, 104: 150-161, Amsterdam: Elsevier, 2017.
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalu1ation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis
Romana Meletta, Roger Slavik, Linjing Mu, Zoran Rancic, Nicole Borel, Roger Schibli, Simon M. Ametamey, Stefanie D. Krämer and Adrienne Müller Herde
Nuclear Medicine and Biology, 47: 31-43, New York, NY: Elsevier, 2017.
GABAA receptor subtypes in the mouse brain: Regional mapping and diazepam receptor occupancy by in vivo [18F]flumazenil PET
Adrienne Müller Herde, Dietmar Benke, William T. Ralvenius, Linjing Mu, Roger Schibli, Hans U. Zeilhofer and Stefanie D. Krämer
Neuroimage, 150: 279-291, Amsterdam: Elsevier, 2017.
CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers
Romana Meletta, Larissa Steier, Nicole Borel, Linjing Mu, Claudia Keller, Aristeidis Chiotellis, Erica Russo, Cornelia Halin, Simon M. Ametamey, Roger Schibli, Stefanie D. Krämer and Adrienne Müller Herde
Molecular Imaging and Biology, 19 (1): 90-99, New York, NY: Springer, 2017.

2016

Synthesis and Pharmacological Evaluation of [(11)C]Granisetron and [(18)F]Fluoropalonosetron as PET Probes for 5-HT(3) Receptor Imaging
Linjing Mu, Adrienne Müller Herde, Pascal M. Rüefli, Filippo Sladojevich, Selena Milicevic Sephton, Stefanie D. Krämer, Andrew J. Thompson, Roger Schibli, Simon M. Ametamey and Martin Lochner
ACS Chemical Neuroscience, 7 (11): 1552-1564, Washington, DC: American Chemical Society, 2016.
Enhanced sensitivity to drugs of abuse and palatable foods following maternal overnutrition
Daria Peleg-Raibstein, Gitalee Sarker, Kathrin Litwan, Stefanie D. Krämer, Simon M. Ametamey, Roger Schibli and Christian Wolfrum
Translational Psychiatry, 6 (10): e911, London: Nature Publishing Group, 2016.
Noninvasive PET Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering
Deana Haralampieva, Thomas Betzel, Ivana Dinulovic, Souzan Salemi, Meline Stoelting, Stefanie D. Krämer, Roger Schibli, Tullio Sulser, Christoph Handschin, Daniel Eberli and Simon M. Ametamey
The Journal of Nuclear Medicine : JNM, 57 (9): 1467-1473, New York, NY: Society of Nuclear Medicine, 2016.
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Roger Slavik, Adrienne Müller Herde, Ahmed Haider, Stefanie D. Krämer, Markus Weber, Roger Schibli, Simon M. Ametamey and Linjing Mu
Journal of Neurochemistry, 138 (6): 874-886, Oxford: Wiley-Blackwell, 2016.
Synthesis, Radiolabeling, and Biological Evaluation of 5-Hydroxy-2- F-18 fluoroalkyl-tryptophan Analogues as Potential PET Radiotracers for Tumor Imaging
Aristeidis Chiotellis, Adrienne Müller Herde, Simon L. Rössler, Ante Brekalo, Erika Gedeonova, Linjing Mu, Claudia Keller, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Journal of Medicinal Chemistry, 59 (11): 5324-5340, Washington, DC: American Chemical Society, 2016.
When barriers ignore the “rule-of-five”
Stefanie D. Krämer, Hélène E. Aschmann, Maja Hatibovic, Katharina F. Hermann, Claudia S. Neuhaus, Cyrill Brunner and Sara Belli
Advanced Drug Delivery Reviews, 101: 62-74, Amsterdam: Elsevier, 2016.
Quantitative aspects of drug permeation across in vitro and in vivo barriers
Stefanie D. Krämer
European Journal of Pharmaceutical Sciences, 87: 30-46, Amsterdam: Elsevier, 2016.
Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis
Romana Meletta, Herde Adrienne Müller, Patrick Dennler, Eliane Fischer, Roger Schibli and Stefanie D. Krämer
EJNMMI Research, 6: 1, Berlin: Springer, 2016.

2015

Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaques
Romana Meletta, Nicole Borel, Paul Stolzmann, Alberto Astolfo, Jan Klohs, Marco Stampanoni, Markus Rudin, Roger Schibli, Stefanie D. Krämer and Adrienne Müller Herde
The International Journal of Cardiovascular Imaging, 31 (7): 1425-1434, Dordrecht: Kluwer Academic, 2015.
Quantitative positron emission tomography (PET) of mGluR5 in rat brain with [18F]PSS232 at minimal invasiveness and reduced model complexity
Adrienne Müller Herde, Claudia Keller, Selena Milicevic Sephton, Linjing Mu, Roger Schibli, Simon M. Ametamey and Stefanie D. Krämer
Journal of Neurochemistry, 133 (3): 330-342, Oxford: Wiley-Blackwell, 2015.
Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor
Roger Slavik, Uwe Grether, Adrienne Müller Herde, Luca Gobbi, Jürgen Fingerle, Christoph Ullmer, Stefanie D. Kramer, Roger Schibli, Linjing Mu and Simon M. Ametamey
Journal of Medicinal Chemistry, 58 (10): 4266-4277, Washington, DC: American Chemical Society, 2015.
Synthesis and pharmacological evaluation of 11C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging
Svetlana V. Selivanova, Annamaria Toscano, Carmen Abate, Francesco Berardi, Adrienne Müller, Stefanie D. Krämer, Roger Schibli and Simon M. Ametamey
Nuclear Medicine and Biology, 42 (4): 399-405, New York, NY: Elsevier, 2015.
Evaluation of the radiolabeled boronic acid-based FAP Inhibitor MIP-1232 for atherosclerotic plaque imaging
Romana Meletta, Adrienne Müller Herde, Aristeidis Chiotellis, Isa Malsor, Zoran Rancic, Nicole Borel, Simon M. Ametamey, Stefanie D. Krämer and Roger Schibli
Molecules, 20 (2): 2081-2099, S.l.: MDPI, 2015.
Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5)
Selena Milicevic Sephton, Adrienne Müller Herde, Linjing Mu, Claudia Keller, Sonja Rüdisühli, Yves Auberson, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
European Journal of Nuclear Medicine and Molecular Imaging, 42 (1): 128-137, Berlin: Springer, 2015.
Preclinical imaging of the co-stimulatory ligands CD80/CD86 with 111In-DOTA-Belatacept in oncology and atherosclerosis
Adrienne Herde, Romana Meletta, P. Dennler, E. Fischer, Roger Schibli and Stefanie D. Krämer
European Journal of Nuclear Medicine and Molecular Imaging, 42 (Supplement 1): S85-S86, Berlin: Springer, 2015.
Positron Emission Tomography (PET): Quantification and Kinetic Modeling
Stefanie D. Krämer
In Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, edited by Reedijk, Jan, Amsterdam: Elsevier, 2015.
Quantification of Available NMDA (GluN) Receptor NTD Drug Binding Sites with the GluN2B-targeting PET Tracer C-11 NB1
Stefanie D. Krämer, T. Betzel, L. Mu, B. Tewes, B. Frehland, D. Schepmann, Roger Schibli, B. Wunsch and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, 42 (Supplement 1): S120-S120, Berlin: Springer, 2015.
Discovery of a Fluorinated 4-Oxo-Quinoline Derivative as a Potential PET Radiotracer for Targeting CB2 Receptor
L. Mu, R. Slavik, A.H. Muller, Stefanie D. Krämer, M. Weber, Roger Schibli and Simon M. Ametamey
European Journal of Nuclear Medicine and Molecular Imaging, 42 (Supplement 1): S118-S118, Berlin: Springer, 2015.
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor
Roger Slavik, Adrienne Müller Herde, Daniel Bieri, Markus Weber, Roger Schibli, Stefanie D. Krämer, Simon M. Ametamey and Linjing Mu
European Journal of Medicinal Chemistry, 92: 554-564, Paris: Elsevier, 2015.
Accurate molecular imaging of small animals taking into account animal models, handling, anaesthesia, quality control and imaging system performance
Christian Vanhove, Jens P. Bankstahl, Stefanie D. Krämer, Eric Visser, Nicola Belcari and Stefaan Vandenberghe
EJNMMI Phys, 2: 31, Heidelberg: Springer, 2015.

2014

Cell-Free Microfluidic Determination of P-glycoprotein Interactions with Substrates and Inhibitors
Klaus Eyer, Michael Herger, Stefanie D. Krämer and Petra S. Dittrich
Pharmaceutical Research, 31 (12): 3415-3425, Berlin: Springer, 2014.
Synthesis and biological evaluation of ((5-hydroxy(2-(3-[18F]fluoropropyl))tryptophan ([18F]5OH-2FPTRP) as a potential PET tumor imaging agent
A. Chiotellis, A. Müller, L. Mu, S. Rössler, C. Keller, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, 41 (Supplement 2): 262-263, Berlin: Springer, 2014.
Radioligand development for imaging cannabinoid receptor subtype 2 with PET
L. Mu, R. Slavik, A. Muller, M. Weber, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, 41 (2 Supplement): S325-S325, Berlin: Springer, 2014.
Targeting the Immune Co-Stimulatory Molecule CD80 for the Imaging of Vulnerable Atherosclerotic Plaques by Pet
R. Meletta, A. Müller, L. Mu, A. Chiotellis, N. Borel, Z. Rancic, P.A. Kaufmann, Simon M. Ametamey, Roger Schibli and Stefanie D. Krämer
Atherosclerosis, 235 (2): E230-E230, Amsterdam: Elsevier, 2014.
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability
Adrienne Mueller, Stefanie D. Krämer, Romana Meletta, Katharina Beck, Svetlana V. Selivanova, Zoran Rancic, Philipp A. Kaufmann, Bernhard Vos, Jörg Meding, Timo Stellfeld, Tobias K. Heinrich, Marcus Bauser, Joachim Huetter, Ludger M. Dinkelborg, Roger Schibli and Simon M. Ametamey
Nuclear medicine and biology, 41 (7): 562-569, New York, NY: Elsevier, 2014.
Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules
Adrienne Müller, Linjing Mu, Romana Meletta, Katharina Beck, Zoran Rancic, Konstantin Drandarov, Philipp A. Kaufmann, Simon M. Ametamey, Roger Schibli, Nicole Borel and Stefanie D. Krämer
International journal of cardiology, 174 (3): 503-515, Amsterdam: Elsevier, 2014.
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition
Dennis Smith, Per Artursson, Alex Avdeef, Li Di, Gerhard F. Ecker, Bernhard Faller, Brian J. Houston, Manfred Kansy, Edward H. Kerns, Stefanie D. Krämer, Hans Lennernäs, Han van de Waterbeemd, Kiyohiko Sugano and Bernard Testa
Molecular pharmaceutics, 11 (6): 1727-1738, Washington, DC: American Chemical Society, 2014.
Imaging Tumour ATB0,+ Transport Activity by PET with the Cationic Amino Acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine
Adrienne Müller, Aristeidis Chiotellis, Claudia Keller, Simon M. Ametamey, Roger Schibli, Linjing Mu and Stefanie D. Krämer
Molecular imaging and biology, 16 (3): 412-420, New York: Springer, 2014.
MRS glucose mapping and PET joining forces: Re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia
Malte F. Alf, João M.N. Duarte, Hongxia Lei, Stefanie D. Krämer, Vladimir Mlynarik, Roger Schibli and Rolf Gruetter
Journal of Neurochemistry, 129 (4): 672-682, Oxford: Wiley-Blackwell, 2014.
Development and Evaluation of Novel PET Tracers for Imaging Cannabinoid Receptor Type 2 in Brain
R. Slavik, D. Bieri, S. Cermak, A. Muller, Stefanie D. Krämer, M. Weber, Roger Schibli, Simon M. Ametamey and L.J. Mu
Chimia, 68 (4): 208-210, Bern: Swiss Chemical Society, 2014.
Synthesis and preliminary evaluation of a 2-Oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor
Linjing Mu, Roger Slavik, Adrienne Müller, Kasim Popaj, Stjepko Čermak, Markus Weber, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Pharmaceuticals, 7 (3): 339-352, Switzerland: MDPI AG, 2014.
Imaging Atherosclerotic Plaque Inflammation via Folate Receptor Targeting Using a Novel F-18-Folate Radiotracer
Adrienne Müller, Katharina Beck, Zoran Rancic, Cristina Müller, Cindy R. Fischer, Thomas Betzel, Philipp A. Kaufmann, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Molecular Imaging, 13 (2): 1-11, Lewiston, NY: BC Decker, 2014.
A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer
K. Eyer, F. Paech, F. Schuler, P. Kuhn, R. Kissner, S. Belli, Petra S. Dittrich and Stefanie D. Krämer
Journal of Controlled Release, 173 (1): 102-109, Amsterdam: Elsevier, 2014.
Synthesis and Biological Evaluation of 18F-Labeled Fluoroethoxy Tryptophan Analogues as Potential PET Tumor Imaging Agents
Aristeidis Chiotellis, Adrienne Müller, Linjing Mu, Claudia Keller, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Molecular pharmaceutics, 11 (11): 3839-3851, Washington, DC: American Chemical Society, 2014.
Synthesis and preliminary biological evaluation of O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine ([18F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging
Aristeidis Chiotellis, Adrienne Müller, Karin Weyermann, Dominique S. Leutwiler, Roger Schibli, Simon M. Ametamey, Stefanie D. Krämer and Lingjing Mu
Amino Acids, 46 (8): 1947-1438-2199, Wien: Springer, 2014.

2013

Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of sigma(2) receptors
Carmen Abate, Svetlana V. Selivanova, Adrienne Muller, Stefanie D. Kramer, Roger Schibli, Roberta Marottoli, Roberto Perrone, Francesco Berardi, Mauro Niso and Simon M. Ametamey
European journal of medicinal chemistry, 69: 920-930, Paris: Elsevier, 2013.
Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ2 receptors
Carmen Abate, Svetlana V. Selivanova, Adrienne Müller, Stefanie D. Krämer, Roger Schibli, Roberta Marottoli, Roberto Perrone, Francesco Berardi, Mauro Niso and Simon M. Ametamey
European journal of medicinal chemistry, 69: 920-930, Paris: Elsevier, 2013.
FEMAET: a Cationic Amino Acid PET Probe Targeting the Concentrative Amino Acid Transporter ATB0,+
Stefanie D. Krämer, A. Müller, A. Chiotellis, L. Mu, C. Keller, Simon M. Ametamey and Roger Schibli
European journal of nuclear medicine and molecular imaging, 40: 153-153, Berlin: Springer, 2013.
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Linjing Mu, Daniel Bieri, Roger Slavik, Konstantin Drandarov, Adrienne Müller, Stjepko Čermak, Markus Weber, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Journal of neurochemistry, 126 (5): 616-624, Oxford: Wiley-Blackwell, 2013.
FDG kinetic modeling in small rodent brain PET: Optimization of data acquisition and analysis
Malte F. Alf, Marianne I. Martić-Kehl, Roger Schibli and Stefanie D. Krämer
EJNMMI research, 3: 61, Heidelberg: Springer, 2013.
Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models
Carmen Campanile, Matthias J.E. Arlt, Stefanie D. Krämer, Michael Honer, Ana Gvozdenovic, Patrick Brennecke, Cindy R. Fischer, Adam A. Sabile, Adrienne Müller, Simon M. Ametamey, Walter Born, Roger Schibli and Bruno Fuchs
The journal of nuclear medicine, 54 (8): 1362-1368, New York: Society of Nuclear Medicine, 2013.
Synthesis and In Vitro Evaluation of E- and Z-Geometrical Isomers of PSS232 as Potential Metabotropic Glutamate Receptors Subtype 5 (mGlu(5)) Binders
Selena M. Sephton, Linjing J. Mu, Martina Dragic, Stefanie D. Kramer, Roger Schibli and Simon M. Ametamey
Synthesis, 45 (13): 1877-1885, Stuttgart: Thieme, 2013.
Design, Synthesis, and Initial Evaluation of a High Affinity Positron Emission Tomography Probe for Imaging Matrix Metalloproteinases 2 and 9
Svetlana V. Selivanova, Timo Stellfeld, Tobias K. Heinrich, Adrienne Müller, Stefanie D. Krämer, P. August Schubiger, Roger Schibli, Simon M. Ametamey, Bernhard Vos, Jörg Meding, Marcus Bauser, Joachim Hütter and Ludger M. Dinkelborg
Journal of medicinal chemistry, 56 (12): 4912-4920, Washington, DC: American Chemical Society, 2013.
F-18 -PSS232-A novel PET radiotracer for imaging of metabotropic glutamate receptors subtype 5 (mGluR5)
S. M. Sephton, L. J. Mu, A. Muller, C. Keller, Stefanie D. Krämer, Roger Schibli and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, 56: S298-S298, Hoboken, NJ, USA: Wiley-Blackwell, 2013.
Synthesis and in vitro/in vivo pharmacological evaluation of [11C]-ThioABP, a novel radiotracer for imaging mGluR5 with PET
Selena Sephton, Linjing Mu, Adrienne Müller, Cindy A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Medchemcomm, 4 (3): 520-526, Cambridge: Royal Society of Chemistry, 2013.
Radiosynthesis and Preclinical Evaluation of 3 '-Aza-2 '- F-18 fluorofolic Acid: A Novel PET Radiotracer for Folate Receptor Targeting
Thomas Betzel, Cristina Müller, Viola Groehn, Adrienne Müller, Josefine Reber, Cindy R. Fischer, Stefanie D. Krämer, Roger Schibli and Simon M. Ametamey
Bioconjugate Chemistry, 24 (2): 205-214, Washington, DC: American Chemical Society, 2013.
Quantification of Brain Glucose Metabolism by F-18-FDG PET with Real-Time Arterial and Image-Derived Input Function in Mice
Malte F. Alf, Matthias T. Wyss, Alfred Buck, Bruno Weber, Roger Schibli and Stefanie D. Krämer
Journal of Nuclear Medicine, 54 (1): 132-138, New York: Society of Nuclear Medicine, 2013.
Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET Imaging agent for HSV1-tk gene Expression
Ursina Müller, Tobias L. Ross, Charlene Ranadheera, Roger Slavik, Adrienne Müller, Mariana Born, Evelyn Trauffer, Selena Milicevic Sephton, Leonardo Scapozza, Stefanie D. Krämer and Simon M. Ametamey
American journal of nuclear medicine and molecular imaging, 3 (1): 71-84, Madison, Wis.: e-Century Publ., 2013.
Brain Glucose Transport and Phosphorylation Under Acute Insulin-Induced Hypoglycemia in Mice: An 18F-FDG PET Study
Malte F. Alf, João. M. N. Duarte, Roger Schibli, Rolf Gruetter and Stefanie D. Kramer
Journal of Nuclear Medicine, 54 (12): 2153-2160, New York: Society of Nuclear Medicine, 2013.
Synthesis and biological evaluation of 18F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging
Aristeidis Chiotellis, Linjing Mu, Adrienne Müller, Svetlana V. Selivanova, Claudia Keller, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
European journal of medicinal chemistry, 70: 768-780, Paris: Elsevier, 2013.
Studies toward the development of new silicon-containing building blocks for the direct 18F-labeling of peptides
Lukas O. Dialer, Svetlana V. Selivanova, Carmen J. Müller, Adrienne Müller, Timo Stellfeld, Keith Graham, Ludger M. Dinkelborg, Stefanie D. Krämer, Roger Schibli, Markus Reiher and Simon M. Ametamey
Journal of medicinal chemistry, 56 (19): 7552-7563, Washington, DC: American Chemical Society, 2013.
Development of novel cannabinoid type 2 receptor tracers for PET imaging
Linjing Mu, Roger Slavik, Daniel Bieri, Konstantin Drandarov, Adrienne Muller, Stefanie D. Krämer, Roger Schibli and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, 56: S80-S80, Hoboken, NJ, USA: Wiley-Blackwell, 2013.

2012

Evaluation of fluorescence anisotropy to assess drug–lipid membrane partitioning
Juan M. Pallicer and Stefanie D. Krämer
Journal of pharmaceutical and biomedical analysis, 71: 219-227, Amsterdam: Elsevier, 2012.
Comparison of two F-18-labeled folate PET tracers, following the integrated approach
T. Betzel, C. Müller, V. Gröhn, A. Müller, J. Reber, Stefanie D. Krämer, Roger Schibli and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, 39 (S2): S267-S267, New York, NY, USA: Springer, 2012.
Synthesis, radiolabelling and in vitro/in vivo evaluation of a novel PET ligand for imaging of metabotropic glutamate receptor subtype 5
L. Mu, S.M. Sephton, A. Müller, C.A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, 39: S258-S258, New York, NY, USA: Springer, 2012.
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
Li Di, Per Artursson, Alex Avdeef, Gerhard F. Ecker, Bernard Faller, Holger Fischer, J. Brian Houston, Manfred Kansy, Edward H. Kerns, Stefanie D. Kramer, Hans Lennernäs and Kiyohiko Sugano
Drug Discovery Today, 17 (15-16): 905-912, Amsterdam: Elsevier, 2012.
Expression Profiles of Metabolic Enzymes and Drug Transporters in the Liver and along the Intestine of Beagle Dogs
Stephanie Haller, Franz Schuler, Stanley E. Lazic, Dalila Bachir-Cherif, Stefanie D. Krämer, Neil J. Parrott, Guido Steiner and Sara Belli
Drug Metabolism and Disposition, 40 (8): 1603-1611, Bethesda, Md.: ASPET, 2012.
Synthesis and evaluation of novel alpha-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers
Selena Milicevic Sephton, Linjing Mu, W. Bernd Schweizer, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Journal of medicinal chemistry, 55 (16): 7154-7162, Washington, DC: American Chemical Society, 2012.
Synthesis and Evaluation of Novel α-Fluorinated (E)-3-((6-Methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl Oxime (ABP688) Derivatives as Metabotropic Glutamate Receptor Subtype 5 PET Radiotracers
Selena Milicevic Sephton, Linjing Mu, W. Bernd Schweizer, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
Journal of medicinal chemistry, 55 (16): 7154-7162, Washington, DC: American Chemical Society, 2012.
Radiofluorinated histamine H-3 receptor antagonist as a potential probe for in vivo PET imaging: Radiosynthesis and pharmacological evaluation
Svetlana V. Selivanova, Michael Honer, Francine Combe, Kathleen Isensee, Holger Stark, Stefanie D. Krämer, P. August Schubiger and Simon M. Ametamey
Bioorganic & medicinal chemistry, 20 (9): 2889-2896, Amsterdam: Elsevier, 2012.
[18F]Fluoro-Deoxy-Glucose Folate: A Novel PET Radiotracer with Improved in Vivo Properties for Folate Receptor Targeting
Cindy R. Fischer, Cristina Müller, Josefine Reber, Adrienne Muller, Stefanie D. Krämer, Simon M. Ametamey and Roger Schibli
Bioconjugate Chemistry, 23 (4): 805-813, Washington, D.C.: American Chemical Society, 2012.
Development of F-18 -PSS223 as a PET Tracer for Imaging of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)
Selena Milicevic Sephton, Patrick Dennler, Dominique S. Leutwiler, Linjing Mu, Roger Schibli, Stefanie D. Kramer and Simon M. Ametamey
Chimia, 66 (4): 201-204, Bern: Swiss Chemical Society, 2012.
5-(2-F-18-Fluoroethoxy)-L-Tryptophan as a Substrate of System L Transport for Tumor Imaging by PET
Stefanie D. Kramer, Linjing Mu, Adrienne Müller, Claudia Keller, Olga F. Kuznetsova, Christian Schweinsberg, Dominic Franck, Cristina Muller, Tobias L. Ross, Roger Schibli and Simon M. Ametamey
The journal of nuclear medicine, 53 (3): 434-442, New York: Society of Nuclear Medicine, 2012.
Synthesis and evaluation of a C-6 alkylated pyrimidine derivative for the in vivo imaging of HSV1-TK gene expression
Ursina Müller, Miljen Martic, Tatjana Gazivoda Kraljevic, Svjetlana Kristafor, Tobias L. Ross, Charlene Ranadheera, Adrienne Müller, Mariana Born, Stefanie D. Krämer, Silvana Raic-Malic and Simon M. Ametamey
Nuclear Medicine and Biology, 39 (2): 235-246, New York: Elsevier, 2012.
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5
Selena Milicevic Sephton, Patrick Dennler, Dominique S. Leutwiler, Linjing Mu, Cindy A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer and Simon M. Ametamey
American journal of nuclear medicine and molecular imaging, 2 (1): 14-28, Madison, Wis.: e-Century Publ., 2012.

2011

Anti-VEGF antibody treatment accelerates polycystic kidney disease
Shagun Raina, Michael Honer, Stefanie D. Krämer, Yang Liu, Xueqi Wang, Stephan Segerer, Rudolf P. Wuthrich and Andreas L. Serra
American journal of physiology, 301 (4): F773-F783, Boston: American Physiological Society, 2011.
(18)F-Labeling, in vitro and in vivo studies of a bombesin analogue for the imaging of GRP receptor-positive prostate cancer
L.O. Dialer, S.V. Selivanova, Stefanie D. Krämer, A. Muller, Roger Schibli, Simon M. Ametamey, T. Stellfeld, K. Graham, S. Borkowski, L.M. Dinkelborg and A. Srinivasan
Journal of labelled compounds and radiopharmaceuticals, 54 (S1): 177-177, Chichester, UK: Wiley, 2011.
Radiosynthesis, in vitro and in vivo characterization of O-(2- (18)F fluoroethyl)-5-hydroxy-L-tryptophan
L. Mu, O. Kuznetsova, C. Schweinsberg, A. Muller, C. Muller, T. Ross, D. Franck, Roger Schibli and Stefanie D. Krämer
Journal of labelled compounds and radiopharmaceuticals, 54 (S1): 32-32, Chichester: Wiley, 2011.
In vitro and in vivo evaluation of [F-18]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5)
Cindy A. Wanger-Baumann, Linjing Mu, Michael Honer, Sara Belli, Malte F. Alf, Pius A. Schubiger, Stefanie D. Krämer and Simon M. Ametamey
NeuroImage, 56 (3): 984-991, Amsterdam: Elsevier, 2011.
Development of A [F-18]-labelled analogue of [C-11]-ABP688 for the pet imaging of the metabotropic glutamate receptor subtype 5 (MGLUR5)
C.A. Baumann, L. Mu, M. Honer, Stefanie D. Krämer, P.A. Schubiger and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, 54 (5): 280-281, Chichester: Wiley, 2011.
Muscle precursor cells are safe for the treatment of urinary incontinence after surgery for prostate cancer
M.N.L. Stölting, Stefanie D. Krämer, Simon M. Ametamey, S. Ferrari, A. Becskei, T. Sulser and D. Eberli
European urology. Supplements, 10 (2): 311-311, Amsterdam: Elsevier Science, 2011.
Pharmacokinetics and safety of panobacumab: Specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Qin Lu, Jean-Jacques Rouby, Pierre-Francois Laterre, Philippe Eggimann, Anthony Dugard, Evangelos J. Giamarellos-Bourboulis, Emanuelle Mercier, Jorge Garbino, Charles-Edouard Luyt, Jean Chastre, Violetta Georgescu-Kyburz, Michael P. Rudolf, Verena Gafner, Hedvika Lazar, Holger Koch, Antonio Perez, Stefanie D. Krämer and Michael Tamm
The journal of antimicrobial chemotherapy, 66 (5): 1110-1116, Oxford, UK: Oxford University Press, 2011.

2010

Particle size and activation threshold: A new dimension of danger signaling
Lorna Rettig, Sebastian P. Haen, Anne Greet Bittermann, Lotta von Böhmer, Alessandra Curioni, Stefanie D. Krämer, Alexander Knuth and Steve Pascolo
Blood, 115 (22): 4533-4541, Washington, DC: American Society of Hematology, 2010.
Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands
Cindy A. Baumann, Linjing Mu, Nicole Wertli, Stefanie D. Krämer, Michael Honer, Pius A. Schubiger and Simon M. Ametamey
Bioorganic & medicinal chemistry, 18 (16): 6044-6054, Amsterdam: Elsevier, 2010.
The biochemistry of drug metabolism. 2, Conjugations, consequences of metabolism, influencing factors
Bernard Testa and Stefanie D. Krämer
Zürich: Helvetica Chimica Acta Wiley-VCH, 2010.

2009

Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
Dario Lombardi, Bernard Cuenoud and Stefanie D. Krämer
European journal of pharmaceutical sciences, 38 (5): 533-547, Amsterdam: Elsevier, 2009.
Why and how pharmacokinetics change from birth to adolescence: An introduction
Stefanie D. Krämer
Bulletin technique Gattefossé, 102: 9-17, Saint-Priest: Gattefossé, 2009.
Lipid-bilayer permeation of drug-like compounds
Stefanie D. Krämer, Dario Lombardi, Adriana Primorac, Anita V. Thomae and Heidi Wunderli-Allenspach
Chemistry & biodiversity, 6 (11): 1900-1916, Zürich: Verlag Helvetica Chimica Acta, 2009.
Cholesterol-mediated activation of P-glycoprotein: Distinct effects on basal and drug-induced ATPase activities
Sara Belli, Priska M. Elsener, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Journal of pharmaceutical sciences, 98 (5): 1905-1918, New York: Wiley, 2009.
The Biochemistry of Drug Metabolism - An Introduction: Part 7. Intra-Individual Factors Affecting Drug Metabolism
Stefanie D. Krämer and Bernard Testa
Chemistry & Biodiversity, 6 (10): 1477-1660, Zürich: Verlag Helvetica Chimica Acta, 2009.
Interaction kinetics of salmeterol with egg phosphatidylcholine liposomes by surface plasmon resonance
Dario Lombardi, Bernard Cuenoud, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Analytical biochemistry : methods in the biological sciences, 385 (2): 215-223, San Diego: Elsevier, 2009.
Suitability of Endothelin Receptor Subtype A as a Target for PET Imaging of Atherosclerotic Plaques
T.L. Ross, M. Honer, S. Belli, Stefanie D. Krämer, J. Kelm, S.P. Hoerstrup, P. Kaufmann, A.P. Schubiger and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, 52 (S1): S119-S119, Chichester: Wiley, 2009.
The Biochemistry of Drug Metabolism: An Introduction. Part 5. Metabolism and Bioactivity
Bernard Testa and Stefanie D. Krämer
Chemistry & biodiversity, 6 (5): 591-684, Zürich: Wiley, 2009.

2008

Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis
G. di Maira, F. Brustolon, K. Tosoni, S. Belli, Stefanie D. Krämer, L. A. Pinna and M. Ruzzene
Molecular and cellular biochemistry, 316 (01-Feb): 155-156, Berlin: Springer, 2008.
Dynamics and Cleavability at the α-Cleavage Site of APP(684-726) in Different Lipid Environments
Marco Marenchino, Philip T.F. Williamson, Samuel Murri, Giorgia Zandomeneghi, Heidi Wunderli-Allenspach, Beat H. Meier and Stefanie D. Krämer
Biophysical journal, 95 (3): 1460-1473, Bethesda, MD: Biophysical Society, 2008.
The biochemistry of drug metabolism: An introduction: Part 6. Inter-individual factors affecting drug metabolism
Stefanie D. Krämer and B. Testa
Chemistry & biodiversity, 5 (12): 2465, Zürich: Wiley, 2008.
The Biochemistry of Drug Metabolism - An Introduction: Part 6. Inter-Individual Factors Affecting Drug Metabolism
Stefanie D. Krämer and Bernard Testa
Chemistry & biodiversity, 5 (12): 2465-2578, Zürich: Verlag Helvetica Chimica Acta, 2008.
Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis
Giovanni Di Maira, Francesca Brustolon, Kendra Tosoni, Sara Belli, Stefanie D. Krämer, Lorenzo A. Pinna and Maria Ruzzene
Molecular and Cellular Biochemistry, 316 (1-2): 155-161, Berlin: Springer, 2008.
The biochemistry of drug metabolism: An introduction: part 4. reactions of conjugation and their enzymes
Bernard Testa and Stefanie D. Krämer
Chemistry & biodiversity : an official journal of the Center for the Study of Biological Complexity (CSBC), Virgina Commonwealth University, USA, 5 (11): 2171-2336, Zürich: Verlag Helvetica Chimica Acta, 2008.
The biochemistry of drug metabolism. 1, Principles, redox reactions, hydrolyses
Bernard Testa and Stefanie D. Krämer
Zürich: Helvetica Chimica Acta Wiley-VCH, 2008.

2007

P-Glycoprotein in proteoliposomes with low residual detergent: The effects of cholesterol
Karsten Bucher, Sara Belli, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Pharmaceutical research, 24 (11): 1993-2004, Berlin: Springer, 2007.
Kinetic study of drug/lipid membrane interactions with surface plasmon resonance (SPR)
Dario Lombardi, Bernard Cuenoud and Stefanie D. Krämer
Biophysical journal, 2007 (Supplement): 239A-239A, Cambridge, MA: Cell Press ; Elsevier, 2007.
Permeation of a β-heptapeptide derivative across phospholipid bilayers
Toshinori Shimanouchi, Peter Walde, James Gardiner, Yogesh R. Mahajan, Dieter Seebach, Anita Thomae, Stefanie D. Krämer, Matthias Voser and Ryoichi Kuboi
Biochimica et biophysica acta, 1768 (11): 2726-2736, Amsterdam: Elsevier, 2007.
The biochemistry of drug metabolism: An introduction - Part 2. Redox reactions and their enzymes
Bernard Testa and Stefanie D. Krämer
Chemistry & biodiversity, 4 (3): 257-405, Zürich: Verlag Helvetica Chimica Acta, 2007.
The biochemistry of drug metabolism - An introduction: Part 3. Reactions of hydrolysis and their enzymes
Bernard Testa and Stefanie D. Krämer
Chemistry & Biodiversity, 4 (9): 2031-2122, Zürich: Verlag Helvetica Chimica Acta, 2007.
Comparing the lipid membrane affinity and permeation of drug-like acids: The intriguing effects of cholesterol and charged lipids
Anita V. Thomae, Tamara Koch, Christian Panse, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Pharmaceutical research, 24 (8): 1457-1472, Berlin: Springer, 2007.
Comparing the lipid membrane affinity and permeation of drug-like acids: The intriguing effects of cholesterol and charged lipids
A.V. Thomae, T. Koch, C. Panse, H. Wunderli-Allenspach and Stefanie D. Krämer
Pharmaceutical research, 24 (8): 1457, Berlin: Springer, 2007.
The obstacle course of drugs in the body: Predictive tools for the in vivo barrier crossing of drugs
H. Wunderli-Allenspach and Stefanie D. Krämer
BioForum Europe, 11 (4): 45-47, Darmstadt: GIT Verlag, 2007.

2006

Role of drug efflux carriers in the healthy and diseased brain
Dirk M. Hermann, Ertugrul Kilic, Annett Spudich, Stefanie D. Krämer, Heidi Wunderli-Allenspach and Claudio L. Bassetti
Annals of neurology, 60 (5): 489-498, New York, NY: Wiley-Blackwell, 2006.
Comparison of permeation through phosphatidylcholine bilayers of N-dipicolinyl-alpha- and -beta-oligopeptides
James Gardiner, Anita V. Thomae, Raveendra I. Mathad, Dieter Seebach and Stefanie D. Krämer
Chemistry & biodiversity, 3 (11): 1181-1201, Zürich: Verlag Helvetica Chimica Acta, 2006.
Lipid bilayer in ADME: Permeation barriers and distribution compartments
Stefanie D. Krämer
In Pharmacokinetic profiling in drug research : biological, physicochemical, and computational strategies, edited by Testa, Bernard, Stefanie D. Krämer and Heidi Wunderli-Allenspach, 203-220, Zürich: Verlag Helvetica Chimica Acta, 2006.
Lipid Bilayers in ADME: Permeation Barriers and Distribution Compartments
Stefanie D. Krämer
In Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, edited by Testa, Bernard, Stefanie D. Krämer, Heidi Wunderli-Allenspach and Gerd Folkers, 203-220, Zürich: Verlag Helvetica Chimica Acta, 2006.
The biochemistry of drug metabolism: An introduction - Part 1. Principles and overview
Bernard Testa and Stefanie D. Krämer
Chemistry & biodiversity, 3 (10): 1053-1101, Zürich: Verlag Helvetica Chimica Acta, 2006.
Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies
Bernard Testa, Stefanie D. Krämer, Heidi Wunderli-Allenspach and Gerd Folkers
Zürich: Verlag Helvetica Chimica Acta, 2006.

2005

Permeation of Aromatic Carboxylic Acids across Lipid Bilayers: The pH-Partition Hypothesis Revisited
Anita V. Thomae, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Biophysical journal, 89 (3): 1802-1811, Cambridge, MA: Elsevier, 2005.
Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells
Sarah W. Kamau, Stefanie D. Krämer, Maja Günthert and Heidi Wunderli-Allenspach
In vitro cellular & developmental biology. Animal, 41 (7): 207-216, Heidelberg: Springer, 2005.
Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities
Carsten Bucher, Camille A. Besse, Sarah W. Kamau, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Pharmaceutical research, 22 (3): 449-457, Berlin: Springer, 2005.
Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P Glycoprotein-related activities
Karsten Bucher, Camille A. Besse, Sarah W. Kamau, Heidi Wunderli-Allenspach and Stefanie D. Krämer
Pharmaceutical research, 22 (3): 449-457, Berlin: Springer, 2005.

2004

Exploring barrier mechanisms relevant for drug therapy
Heidi Wunderli-Allenspach, Karsten Bucher, Jiri Hofmann, Marco Marenchino, Anita Thomae, Maja Günthert and Stefanie D. Krämer
Chimia, 58 (10): 741-744, Bern: Swiss Chemical Society, 2004.
α-Tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner
Marco Marenchino, Andrea L. Alpstäg-Wöhrle, Barbara Christen, Heidi Wunderli-Allenspach and Stefanie D. Krämer
European journal of pharmaceutical sciences, 21 (2-3): 313-321, Amsterdam: Elsevier, 2004.

2003

No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides
Stefanie D. Krämer and H. Wunderli-Allenspach
Biochimica et biophysica acta, 1609 (2): 161-169, Amsterdam: Elsevier, 2003.

2002

Lipids in blood-brain barrier models in vitro I: Thin-layer chromatography and high-performance liquid chromatography for the analysis of lipid classes and long-chain polyunsaturated fatty acids
Stefanie D. Krämer, Johannah A. Hurley, N. Joan Abbott and David J. Begley
In vitro cellular & developmental biology. Animal, 38 (10): 557-565, Heidelberg: Springer, 2002.
Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids
Stefanie D. Krämer, Yanic B. Schütz, Heidi Wunderli-Allenspach, N. Joan Abbott and David J. Begley
In Vitro Cellular & Developmental Biology. Animal, 38 (10): 566-571, Heidelberg: Springer, 2002.

2001

Physicochemical properties in pharmacokinetic lead optimization
Stefanie D. Krämer and Heidi Wunderli-Allenspach
Il Farmaco, 56 (1-2): 145-148, New York, NY: Elsevier Science, 2001.
Liposome/Water Partitioning: Theory, Techniques, and Applications
Stefanie D. Krämer
In Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies, edited by Testa, Bernard, Han van de Waterbeemd, Gerd Folkers and Richard Guy, 401-428, Zürich: Verlag Helvetica Chimica Acta, 2001, 2001.
Biological models to study blood-brain barrier permeation
Stefanie D. Krämer, N. Joan Abbott and David J. Begley
In Pharmacokinetic optimization in drug research : biological, physicochemical, and computational strategies, edited by Testa, Bernard, Han van de Waterbeemd, Gerd Folkers and Richard Guy, 127-154, Zürich: Verlag Helvetica Chimica Acta, 2001.

2000

P-Glycoprotein in cell cultures: A combined approach to study expression, localisation, and functionality in the confocal microscope
Sibylle P. Hämmerle, Barbara Rothen-Rutishauser, Stefanie D. Krämer, Maja M. Günthert and Heidi Wunderli-Allenspach
European journal of pharmaceutical sciences, 12 (1): 69-77, Amsterdam: Elsevier, 2000.
Cell cultures as tools in biopharmacy
Annette Braun, Sibylle Hämmerle, Kayoshi Suda, Barbara Rothen-Rutishauser, Maja M. Günthert, Stefanie D. Krämer and Heidi Wunderli-Allenspach
European journal of pharmaceutical sciences, 11 (Suppl. 2): S51-S60, Amsterdam: Elsevier, 2000.
Permeation Studies In Vitro and In Vivo of Potential Radiopharmaceuticals with Affinity to Neuro Receptors
Matthias Friebe, Kayoshi Suda, Hartmut Spies, Rosmarie Syhre, Ralf Berger, Bernd Johannsen, Efstratios Chiotellis, Stefanie D. Krämer and Heidi Wunderli-Allenspach
Pharmaceutical research, 17 (6): 754-760, Berlin: Springer, 2000.

1999

Absorption prediction from physicochemical parameters
Stefanie D. Krämer
Pharmaceutical science & technology today, 2 (9): 373-380, Kidlington: Elsevier Science, 1999.

1998

MDCK Cell Cultures as an Epithelial In Vitro Model: Cytoskeleton and Tight Junctions as Indicators for the Definition of Age-Related Stages by Confocal Microscopy
Barbara Rothen-Rutishauser, Stefanie D. Krämer, Annette Braun, Maja M. Günthert and Heidi Wunderli-Allenspach
Pharmaceutical research, 15 (7): 964-971, Berlin: Springer, 1998.
Towards the Predictability of Drug-Lipid Membrane Interactions: The pH-Dependent Affinity of Propranolol to Phosphatidylinositol Containing Liposomes
Stefanie D. Krämer, Annette Braun, Christina Jakits-Deiser and Heidi Wunderli-Allenspach
Pharmaceutical research, 15 (5): 739-744, Berlin: Springer, 1998.
Considerations on the potentiometric log P determination
Stefanie D. Krämer, Jean-Claude Gautier and Philippe Saudemon
Pharmaceutical research, 15 (8): 1310, Berlin: Springer, 1998.

1997

Free Fatty Acids Cause pH-Dependent Changes in Drug-Lipid Membrane Interactions Around Physiological pH
Stefanie D. Krämer, Christina Jakits-Deiser and Heidi Wunderli-Allenspach
Pharmaceutical research, 14 (6): 827-832, Berlin: Springer, 1997.

1996

The pH-Dependence in the Partitioning Behaviour of (RS)-[3H]Propranolol Between MDCK Cell Lipid Vesicles and Buffer
Stefanie D. Krämer and Heidi Wunderli-Allenspach
Pharmaceutical research, 13 (12): 1851-1855, Berlin: Springer, 1996.
 
 
Page URL: http://www.biopharmacy.ethz.ch/publications.html
Mon Jul 24 21:32:03 CEST 2017
© 2017 Eidgenössische Technische Hochschule Zürich